アクセス数 : ?
ダウンロード数 : ?
ID 114153
タイトル別表記
マイクロRNA296-5pはBcl2-Related Ovarian Killer遺伝子を介して細胞浸潤と薬剤耐性を促進し、膵癌の不良予後に寄与する
miRNA-296-5p and BOK in Pancreatic Cancer
著者
岡崎, 潤 徳島大学大学院医科学教育部(医学専攻)
棚橋, 俊仁 Tokushima University
Nakamura, Fumika Tokushima University
Ma, Beibei Tokushima University
Bando, Masahiro Tokushima University
キーワード
Apoptosis
Biomarker
Epithelial-mesenchymal transition
MicroRNA
Pancreatic cancer
資料タイプ
学位論文
抄録
Background/Aims: Pancreatic ductal adenocarcinoma (PDAC) is characterized by aggressive invasion, early metastasis, and resistance to chemotherapy, leading to a poor prognosis. To clarify the molecular mechanism of these malignant characteristics, we performed a genome-wide microRNA (miRNA) array analysis utilizing micro-cancer tissues from patients with unresectable PDAC (stage IV), obtained by endoscopic ultrasound-fine needle aspiration (EUS-FNA). Methods: The expression profiles of 2,042 miRNAs were determined using micro-cancer tissues from 13 patients with unresectable PDAC obtained by EUS-FNA. The relationship between individual miRNA levels and overall survival (OS) was analyzed. Possible target genes for miRNAs were bioinformatically analyzed using the online database miRDB. Pancreatic cancer cell lines PANC-1, MIA PaCa-2, and PK-8 were transfected with miRNA mimic or small interfering RNA, and cell invasion, epithelial-mesenchymal transition (EMT), and apoptosis markers were examined. miRNA and mRNA expressions were examined by quantitative polymerase chain reaction. Results: Of 2,042 miRNAs, the 10 that exhibited the lowest correlation coefficient (p ≤ 0.005) between miRNA expression level and OS among the patients were identified. The miRDB and expression analysis in cancer cell lines for the 10 miRNAs identified miR-296-5p and miR-1207-5p as biomarkers predictive of shorter survival (p < 0.0005). Bioinformative target gene analysis and transfection experiments with miRNA mimics showed that Bcl2-related ovarian killer (BOK), a pro-apoptotic gene, is a target for miR296-5p in pancreatic cancer cells; transfection of miR-296-5p mimic into PANC-1, MIA PaCa-2, and PK-8 cells resulted in significant suppression of BOK mRNA and protein expression. These transfectants showed significantly higher invasion capability compared with control cells, and knock down of BOK in pancreatic cancer cells similarly enhanced invasion capability. Transfectants of miR-296-5p mimic also exhibited aberrant expression of EMT markers, including vimentin and N-cadherin. Moreover, these transfectants showed a significantly lower apoptosis rate in response to 5-fluorouracil and gemcitabine with a decrease of BOK expression, suggesting a role of miR-296-5p in drug resistance. Conclusion: These results suggest that miR-296-5p is a useful biomarker for a poor prognosis in patients with PDAC, and that the miR-296-5p/BOK signaling axis plays an important role in cell invasion, drug resistance, and EMT in PDACs.
掲載誌名
Digestion
ISSN
00122823
14219867
cat書誌ID
AA00628636
AA12781324
出版者
Karger
発行日
2019-09-27
備考
内容要旨・審査要旨・論文本文の公開
本論文は,著者Jun Okazakiの学位論文として提出され,学位審査・授与の対象となっている。
権利情報
© 2019 S. Karger AG, Basel
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
博士論文全文を含む
文科省報告番号
甲第3341号
学位記番号
甲医第1433号
学位授与年月日
2019-12-26
学位名
博士(医学)
学位授与機関
徳島大学
部局
医学系
病院